mAb 2-43

General information

mAb 2-43 was identified in a convalescent COVID-19 patient memory B cell screening. It neutralized SARS-CoV-2 live virus with an IC₅₀ of 0.003 μg/mL in vitro (Liu et al., 2020). The antibody’s tertiary structure and interaction with Spike RBD has been described by Rapp et al. (2021).